Hypoxaemic burden in heart failure patients receiving adaptive servo-ventilation.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 07 08 2023
received: 13 02 2023
accepted: 20 09 2023
medline: 29 11 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: ppublish

Résumé

This study aimed to assess the effectiveness of adaptive servo-ventilation (ASV) for lowering hypoxaemic burden components in heart failure with reduced ejection fraction (HFrEF) patients. Fifty-six stable HFrEF patients with left ventricular ejection fraction ≤ 40 were randomized to receive either ASV (n = 27; 25 males) or optimal medical management or optimal medical management alone (n = 29; 26 males). Patients underwent overnight polysomnography at baseline and a 12 week follow-up visit. We quantified hypoxaemic as time spent at <90% oxygen saturation (T90) decomposed into desaturation-related components (T90 ASV effectively suppresses the sleep apnoea-related component of hypoxaemic burden in HFrEF patients. A significant hypoxaemic burden not directly attributable to sleep apnoea but related to the severity of heart failure remains and may adversely affect cardiovascular long-term outcomes.

Identifiants

pubmed: 37794711
doi: 10.1002/ehf2.14556
pmc: PMC10682887
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3725-3728

Subventions

Organisme : Philips Home Healthcare Solutions
Organisme : Philips Respironics
Organisme : ResMed Foundation
Organisme : Else-Kroener Fresenius Foundation

Informations de copyright

© 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Eur Heart J. 2016 Jun 1;37(21):1695-703
pubmed: 26612581
ESC Heart Fail. 2023 Dec;10(6):3725-3728
pubmed: 37794711
J Cardiovasc Transl Res. 2021 Apr;14(2):377-385
pubmed: 32789619
Eur Respir J. 2013 Nov;42(5):1244-54
pubmed: 23222879
N Engl J Med. 2015 Sep 17;373(12):1095-105
pubmed: 26323938
J Sleep Res. 2023 Feb;32(1):e13749
pubmed: 36222010
Sleep Med. 2021 Mar;79:62-70
pubmed: 33482454
Am J Respir Crit Care Med. 2008 May 15;177(10):1150-5
pubmed: 18276938
Eur Respir J. 2017 Jan 18;49(1):
pubmed: 27920092
Int J Cardiol. 2018 Nov 15;271:281-288
pubmed: 30049491
ESC Heart Fail. 2022 Dec;9(6):4100-4111
pubmed: 36052740
Eur Heart J. 2019 Apr 7;40(14):1149-1157
pubmed: 30376054
J Am Coll Cardiol. 2021 Aug 10;78(6):608-624
pubmed: 34353537
Int J Cardiol. 2023 May 1;378:89-95
pubmed: 36841294
Eur Heart J. 2020 Jan 21;41(4):533-541
pubmed: 30590586

Auteurs

Mathias Baumert (M)

Discipline of Biomedical Engineering, School of Electrical and Mechanical Engineering, The University of Adelaide, Adelaide, SA, 5005, Australia.

Dominik Linz (D)

Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute, Maastricht, The Netherlands.
Centre for Heart Rhythm Disorders, The University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Michael Pfeifer (M)

Department of Pneumology, Donaustauf Hospital, Donaustauf, Germany.

Maria Tafelmeier (M)

Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.

Philippe Felfeli (P)

Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.

Michael Arzt (M)

Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.

Sobhan S Shahrbabaki (SS)

Discipline of Biomedical Engineering, School of Electrical and Mechanical Engineering, The University of Adelaide, Adelaide, SA, 5005, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH